News from us and our partners

Tags

Topics

0 results

News
31 March, 2023
Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD
News
30 March, 2023
Landmark New England Journal of Medicine publication reports positive results from PROMISE II pivotal trial showing that LimFlow System saves most patients with end-stage peripheral artery disease from major amputation
News
28 March, 2023
Kiro, cutting-edge digital medicine company, raises €13.8 million in Series A funding led by Sofinnova Partners
News
28 March, 2023
Digital Medicine pioneer, deepc, announces €12 million Series A round led by Sofinnova Partners
News
28 March, 2023
Sofinnova Partners launches Digital Medicine Strategy
News
28 March, 2023
BioCorteX raises $5M, led by Sofinnova
News
24 March, 2023
Microphyt appoints two new directors and confirms its focus on sustainable value creation with a new ESG Advisory Committee
News
15 March, 2023
Mediar Therapeutics announces $105 million financing to advance portfolio of first-in-class fibrosis therapies
News
13 March, 2023
Calliditas announces primary endpoint successfully met in Phase 3 NefIgArd trial evaluating Nefecon® in IgA nephropathy
News
7 March, 2023
Enthera initiates Phase 1 trial of Ent001 in healthy volunteers
News
7 March, 2023
Noema Pharma, founded by Sofinnova Partners, raises CHF 103 million (USD112million) in Series B financing
News
1 March, 2023
Elicit Plant appoints Pam Marrone and Johan de Saegher to its Board of Directors
News
1 March, 2023
Chroma Medicine secures $135M in Series B financing to advance breakthrough epigenetic editing technology and expand pipeline of durable precision genomic medicines
News
24 February, 2023
Acquisition of CinCor Pharma complete
News
22 February, 2023
Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)
News
22 February, 2023
Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors

Pixium Vision announces FDA Breakthrough Device Designation for the Prima System in Dry AMD

Landmark New England Journal of Medicine publication reports positive results from PROMISE II pivotal trial showing that LimFlow System saves most patients with end-stage peripheral artery disease from major amputation

Kiro, cutting-edge digital medicine company, raises €13.8 million in Series A funding led by Sofinnova Partners

Digital Medicine pioneer, deepc, announces €12 million Series A round led by Sofinnova Partners

Sofinnova Partners launches Digital Medicine Strategy

BioCorteX raises $5M, led by Sofinnova

Microphyt appoints two new directors and confirms its focus on sustainable value creation with a new ESG Advisory Committee

Mediar Therapeutics announces $105 million financing to advance portfolio of first-in-class fibrosis therapies

Calliditas announces primary endpoint successfully met in Phase 3 NefIgArd trial evaluating Nefecon® in IgA nephropathy

Enthera initiates Phase 1 trial of Ent001 in healthy volunteers

Noema Pharma, founded by Sofinnova Partners, raises CHF 103 million (USD112million) in Series B financing

Elicit Plant appoints Pam Marrone and Johan de Saegher to its Board of Directors

Chroma Medicine secures $135M in Series B financing to advance breakthrough epigenetic editing technology and expand pipeline of durable precision genomic medicines

Acquisition of CinCor Pharma complete

Ferrer acquires worldwide rights to ASN90, an O-GlcNAcase inhibitor from Asceneuron, exclusively to treat Progressive Supranuclear Palsy (PSP)

Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors